Literature DB >> 23116812

Mapping the hand, foot and face representations in the primary motor cortex - retest reliability of neuronavigated TMS versus functional MRI.

Carolin Weiss1, Charlotte Nettekoven2, Anne K Rehme2, Volker Neuschmelting3, Andrea Eisenbeis3, Roland Goldbrunner3, Christian Grefkes4.   

Abstract

INTRODUCTION: Functional magnetic resonance imaging (fMRI) is a frequently used non-invasive mapping technique for investigating the human motor system. Recently, neuronavigated transcranial magnetic stimulation (nTMS) has been established as an alternative approach. We here compared the test-retest reliability of both mapping techniques with regard to the cortical representations of the hand, leg, face and tongue areas.
METHODS: Ten healthy subjects were examined three times (intervals: 3-5days/21-35days) with fMRI and nTMS. Motor-evoked potentials were recorded from the abductor pollicis brevis, plantaris, mentalis and the tongue muscles. The same muscles were activated in an fMRI motor task. Euclidean distances (ED) between hotspots and centers of gravity (CoG) were computed for the respective somatotopic representations. Furthermore, spatial reliability was tested by intersession overlap volumes (OV) and voxel-wise intraclass correlations (ICC).
RESULTS: Feasibility of fMRI was 100% for all body parts and sessions. In contrast, nTMS was feasible in all sessions and subjects only for the hand area, while mappings of the foot (90%), face (70%) and tongue representations (40%) remained incomplete in several subjects due to technical constraints and co-stimulation artifacts. On average, the mean ED of the hotspots was better for fMRI (6.2±1.1mm) compared to nTMS (10.8±1.9mm) while stability of CoG was similar for both methods. Peak voxel reliability (ICC) was high for both methods (>0.8), and there was no influence of inter-session intervals. In contrast, the reliability of mapping the spatial extent of the hand, foot, lips and tongue representations was poor to moderate for both fMRI and nTMS (OVs and ICC<50%). Especially nTMS mappings of the face and tongue areas yielded poor reliability estimates.
CONCLUSION: Both methods are highly reliable when mapping the core region of a given target muscle, especially for the hand representation area. In contrast, mapping the spatial extent of a cortical representation area was only little reliable for both nTMS and fMRI. In summary, fMRI was better suited when mapping motor representations of the head, while nTMS showed equal reliability for mapping the hand and foot representation areas. Hence, both methods may well complement each other.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Intraclass correlation; Motor cortex; Reliability; TMS; Test–retest; fMRI

Mesh:

Year:  2012        PMID: 23116812     DOI: 10.1016/j.neuroimage.2012.10.046

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  49 in total

1.  Exploring the impact of visual and movement based priming on a motor intervention in the acute phase post-stroke in persons with severe hemiparesis of the upper extremity.

Authors:  Jigna Patel; Qinyin Qiu; Mathew Yarossi; Alma Merians; Supriya Massood; Eugene Tunik; Sergei Adamovich; Gerard Fluet
Journal:  Disabil Rehabil       Date:  2016-09-16       Impact factor: 3.033

2.  Multimodal Imaging in Malignant Brain Tumors: Enhancing the Preoperative Risk Evaluation for Motor Deficits with a Combined Hybrid MRI-PET and Navigated Transcranial Magnetic Stimulation Approach.

Authors:  V Neuschmelting; C Weiss Lucas; G Stoffels; A-M Oros-Peusquens; H Lockau; N J Shah; K-J Langen; R Goldbrunner; C Grefkes
Journal:  AJNR Am J Neuroradiol       Date:  2015-10-29       Impact factor: 3.825

3.  Motor cortex representation of deep and superficial neck flexor muscles in individuals with and without neck pain.

Authors:  Edith Elgueta-Cancino; Welber Marinovic; Gwendolen Jull; Paul W Hodges
Journal:  Hum Brain Mapp       Date:  2019-03-05       Impact factor: 5.038

4.  Structural and functional motor cortex asymmetry in unilateral lower limb amputation with phantom limb pain.

Authors:  K Pacheco-Barrios; C B Pinto; F G Saleh Velez; D Duarte; M E Gunduz; M Simis; A C Lepesteur Gianlorenco; J L Barouh; D Crandell; M Guidetti; L Battistella; F Fregni
Journal:  Clin Neurophysiol       Date:  2020-07-15       Impact factor: 3.708

5.  Navigated transcranial magnetic stimulation improves the treatment outcome in patients with brain tumors in motor eloquent locations.

Authors:  Dietmar Frey; Sarah Schilt; Valérie Strack; Anna Zdunczyk; Judith Rösler; Birat Niraula; Peter Vajkoczy; Thomas Picht
Journal:  Neuro Oncol       Date:  2014-06-12       Impact factor: 12.300

Review 6.  The Treatment of Gliomas in Adulthood.

Authors:  Roland Goldbrunner; Maximilian Ruge; Martin Kocher; Carolin Weiss Lucas; Norbert Galldiks; Stefan Grau
Journal:  Dtsch Arztebl Int       Date:  2018-05-21       Impact factor: 5.594

7.  Functional somatotopy revealed across multiple cortical regions using a model of complex motor task.

Authors:  David A Cunningham; Andre Machado; Guang H Yue; Jim R Carey; Ela B Plow
Journal:  Brain Res       Date:  2013-08-03       Impact factor: 3.252

Review 8.  The use of transcranial magnetic stimulation to evaluate cortical excitability of lower limb musculature: Challenges and opportunities.

Authors:  Trisha M Kesar; James W Stinear; Steven L Wolf
Journal:  Restor Neurol Neurosci       Date:  2018       Impact factor: 2.406

9.  [Interdisciplinary neuro-oncology: part 1: diagnostics and operative therapy of primary brain tumors].

Authors:  G Tabatabai; E Hattingen; J Schlegel; W Stummer; U Schlegel
Journal:  Nervenarzt       Date:  2014-08       Impact factor: 1.214

10.  A generalized workflow for conducting electric field-optimized, fMRI-guided, transcranial magnetic stimulation.

Authors:  Nicholas L Balderston; Camille Roberts; Emily M Beydler; Zhi-De Deng; Thomas Radman; Bruce Luber; Sarah H Lisanby; Monique Ernst; Christian Grillon
Journal:  Nat Protoc       Date:  2020-09-30       Impact factor: 13.491

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.